Skip to main content

TableĀ 1 Reactivity to AMA1, MSP1-19, MSP3 and 3D7 lysate stratified by country and gender

From: Acquired immune responses to three malaria vaccine candidates and their relationship to invasion inhibition in two populations naturally exposed to malaria

Ā 

Ghana

Madagascar

Kuskalā€“Wallis

Dunnā€˜s post test

Female (A)

Male (B)

Female (C)

Male (D)

p (A vs. B)

p (C vs. D)

P (A vs. C)

P (B vs. D)

Age (years,Ā Ā±Ā SD)

32.2Ā Ā±Ā 7.4

29.2Ā Ā±Ā 4.7

37.5Ā Ā±Ā 5.1

38.7Ā Ā±Ā 5.7

<0.0001

0.1617

>0.9999

0.001

<0.0001

AMA1 (AU)

1.6 (1.2ā€“1.9)

3.0 (1.9ā€“4.2)

0.7 (0.1ā€“1.3)

0.9 (0.4ā€“1.4)

<0.0001

0.5952

0.2926

<0.0001

0.0011

MSP1-19 (AU)

0.7 (0.5ā€“1.0)

1.5 (0.9ā€“2.0)

0.7 (0.0ā€“1.4)

0.8 (āˆ’0.3ā€“1.9)

0.0002

0.3937

>0.9999

0.0294

0.0043

MSP3 (AU)

1.0 (0.5ā€“1.4)

2.0 (1.5ā€“2.6)

1.0 (0.3ā€“1.7)

0.9 (āˆ’0.2ā€“2.1)

<0.0001

0.0141

>0.9999

0.2725

0.0002

3D7 lysate (AU)

3.5 (2.6ā€“4.4)

5.2 (4.1ā€“6.3)

2.3 (0.9ā€“3.7)

2.4 (1.1ā€“3.7)

<0.0001

0.0423

0.701

0.003

0.0005

Prevalence of antibodies to the variant antigens (%)

Ā 

Chi square test

N

33

45

40

18

Ā 

p (A vs. B)

p (C vs. D)

p (A vs. C)

p (B vs. D)

AMA1

21 (63.6)

34 (75.6)

5 (12.5)

7 (38.9)

Ā 

0.2541

0.0217

<0.0001

0.0058

MSP1-19

6 (18.2)

17 (37.8)

4 (10.0)

2 (11.1)

Ā 

0.0608

0.8977

0.3116

0.0372

MSP3

11 (33.3)

28 (62.2)

9 (22.5)

3 (16.7)

Ā 

0.0117

0.6119

0.3017

0.0011

3D7 lysate

27 (81.8)

44 (87.8)

14 (35)

9 (50.0)

Ā 

0.0148

0.2800

<0.0001

<0.0001

  1. Continuous data are presented as meanĀ Ā±Ā SD for the age and as means with 95Ā % confidence interval for the antigens reactivity and analyzed using the Kruskalā€“Wallis rank sum test and Dunnā€™s post test. Categorical data are presented as proportions and analyzed using a Chi square test